Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta and Apple team up to make Muse AI models run better on Macs

October 15, 2026

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More
Press Release

Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More

By News RoomMarch 30, 20263 Mins Read
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Companion Animal Health Market Size, Share & Trends Analysis Report by Animal, Product, Distribution Channel, End-use, Region, and Segment Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering.

The global companion animal health market, initially valued at USD 25.46 billion in 2025, is on a trajectory to soar to USD 56.41 billion by 2033, driven by a robust CAGR of 10.6% from 2026 to 2033. Key growth factors include rapid advancements in companion animal health, increased zoonotic disease transfers from pets, regulatory changes, and enhanced R&D and procedural innovations.

Innovation in therapeutics, diagnostics, and care delivery is aligning the companion animal health industry with the complex and valuable nature of human healthcare. Advancements in molecular biology, biologics, and formulation science are enabling targeted therapies, supporting disease management long-term. Regulatory frameworks are adapting, with actions like the FDA’s inclusion of Faunamor for minor species in April 2025 highlight the growing acceptance of precision-driven veterinary medicines. The adoption of AI in diagnostics and regenerative medicine is enhancing clinical outcomes and operational efficiency.

Heightened awareness of zoonotic diseases shared by pets and humans is propelling market demand for preventive veterinary interventions. With pets part of everyday lives, associated risks like bacterial infections and vector-borne diseases have emerged as public health concerns. Agencies such as the CDC emphasize preventive care, including vaccinations and parasite control, which now form part of standard pet ownership practices. These practices are prompting year-round prevention efforts, contributing to the frequent need for pharmaceuticals, diagnostics, and vaccines.

Regulatory frameworks are evolving, pivotal to companion animal health market expansion. By improving product approval processes, international cooperation, and modernizing laws, growth is gaining momentum. The U.S. FDA’s CVM, in December 2025, made progress by approving new drugs for conditions like congestive heart failure and antiseptic formulations, demonstrating the regulatory support for significant therapies. Industry groups, including the AVMA, call for updates to regulatory processes to accommodate complexity and innovative paces.

Report Scope

This comprehensive report projects revenue growth at global, regional, and country levels, analyzing industry trends across segments from 2021 to 2033. It segments the market based on animals, products, distribution channels, end use, and regions.

  • Animal Outlook (USD Million, 2021-2033): Dogs, Equine, Cats, Others
  • Product Outlook (USD Million, 2021-2033): Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Others
  • Distribution Channel Outlook (USD Million, 2021-2033): Retail, E-commerce, Hospital Pharmacies
  • End Use Outlook (USD Million, 2021-2033): Point-of-care/In-house testing, Hospitals & Clinics, Others
  • Regional Outlook (USD Million, 2021-2033): North America, Europe, Asia Pacific, Latin America, Middle East & Africa
  • Comprehensive Market Analysis: Detailed insights into regional and segmental market dynamics.
  • Competitive Landscape: Insights into key players’ market presence.
  • Future Trends: Identifying trends and drivers shaping the market’s future.
  • Actionable Recommendations: Strategies for uncovering new revenue channels and informing business decisions.

Key Attributes

Report Attribute Details
No. of Pages 150
Forecast Period 2025-2033
Estimated Market Value (USD) in 2025 $25.46 Billion
Forecasted Market Value (USD) by 2033 $56.41 Billion
Compound Annual Growth Rate 10.6%
Regions Covered Global

The leading players profiled in this Companion Animal Health market report include:

  • Agrolabo S.p.A.
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Norbrook
  • Vetoquinol
  • Virbac
  • Zoetis Services LLC

For more information about this report visit https://www.researchandmarkets.com/r/czz9tp

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Companion Animal Health Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026

Latest News

Friends don’t let friends feed their data to AI agents

October 15, 2026

As bond yields rise, how to pick between a variable or fixed rate mortgage?

October 15, 2026

Carney says he expects nations, including U.S., to stay out of Alberta vote

October 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version